1. Pediatric dose selection;Abernethy DR;Clin Pharmacol Ther,2010
2. WangY.FDA/MCERSI Workshop: Drug Development Programs Where the Dose Was A Problem. October 22 2020.https://cersi.umd.edu/sites/cersi.umd.edu/files/Day%201%20Slide%20Set%20%281%29-1-83.pdf. Accessed January 24 2021.
3. US Food and Drug Administration: General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-clinical-pharmacology-considerations-neonatal-studies-drugs-and-biological-products-guidance. Accessed November 27 2020.
4. Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling;Wang J;J Clin Pharmacol,2015
5. Wide range of perioperative drugs and doses used in inguinal hernia repairs for premature infants;Dorismond C;J Perinatol,2020